Uniting pharma experts worldwide: What to expect at PHARMAP 2025

PHARMAP 2025 brings together experts from all over the world in Berlin, Germany on 14-15 April to share how to make medicine smarter and safer. Leading pharmaceutical companies from the EU, Asia, the North’s America, the Middle East, Africa and others participate in the Congress to find new contacts and expand their network.

While the pharmaceutical supply chain is evolving, global collaboration is key to drive progress, ensure compliance and enhance sustainability. The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2025 provides a chance for pharmaceutical manufacturers, CDMOs, service providers and packaging specialists to connect and discuss the latest industry trends.

The 5th anniversary edition of PHARMAP continues to expand its global reach, attracting participants from Europe, North America, the Middle East, Asia and beyond. The Congress features expert discussions, networking opportunities and case-study presentations from top pharmaceutical companies worldwide, with a primary focus on the European market, where most participants are based.

Among this year’s newcomers is PRO.MED.CS, a Czech pharmaceutical company with its own production plant and research facilities, as well as Gaelic Laboratories, an Irish manufacturer specialising in Beta-Lactam (penicillin) products.

North American’s presence at PHARMAP 2025 is marked by Grand River Aseptic Manufacturing, a U.S.-based CDMO, providing advanced aseptic fill-finish services for liquid vials, lyophilised vials, syringes and cartridges.

Representing Asia, WuXi Biologics and its German facility join PHARMAP 2025 as a Regional Partner. The company offers end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialisation.

From the Middle East and Africa, Marcyrl Pharmaceutical Industries — an EU GMP-certified Egyptian manufacturer — continues to expand its impact across Africa and the GCC region.

Additionally, global pharmaceutical leaders such as Bayer, MSD, Roche, GSK, Takeda, Ferrer, and Johnson & Johnson Innovative Medicine actively participate in PHARMAP, sharing insights on innovations in the manufacturing and packaging industry.

With an expanding worldwide presence, PHARMAP 2025 highlights the importance of collaboration and technological advancement in ensuring the efficiency, safety and accessibility of pharmaceutical products worldwide.

Be part of the future with PHARMAP 2025: https://sh.bgs.group/2g4